Artículo

Biomarkers for neuromyelitis optica: a visual analysis of emerging research trends

Resumen

Neuromyelitis optica is an inflammatory demyelinating disease of the central nervous system that differs from multiple sclerosis. Over the past 20 years, the search for biomarkers for neuromyelitis optica has been ongoing. Here, we used a bibliometric approach to analyze the main research focus in the field of biomarkers for neuromyelitis optica. Research in this area is consistently increasing, with China and the United States leading the way on the number of studies conducted. The Mayo Clinic is a highly reputable institution in the United States, and was identified as the most authoritative institution in this field. Furthermore, Professor Wingerchuk from the Mayo Clinic was the most authoritative expert in this field. Keyword analysis revealed that the terms “neuromyelitis optica” (261 times), “multiple sclerosis” (220 times), “neuromyelitis optica spectrum disorder” (132 times), “aquaporin 4” (99 times), and “optical neuritis” (87 times) were the most frequently used keywords in literature related to this field. Comprehensive analysis of the classical literature showed that the majority of publications provide conclusive research evidence supporting the use of aquaporin-4-IgG and neuromyelitis optica-IgG to effectively diagnose and differentiate neuromyelitis optica from multiple sclerosis. Furthermore, aquaporin-4-IgG has emerged as a highly specific diagnostic biomarker for neuromyelitis optica spectrum disorder. Myelin oligodendrocyte glycoprotein-IgG is a diagnostic biomarker for myelin oligodendrocyte glycoprotein antibody-associated disease. Recent biomarkers for neuromyelitis optica include cerebrospinal fluid immunological biomarkers such as glial fibrillary acidic protein, serum astrocyte damage biomarkers like FAM19A5, serum albumin, and gamma-aminobutyric acid. The latest prospective clinical trials are exploring the potential of these biomarkers. Preliminary results indicate that glial fibrillary acidic protein is emerging as a promising candidate biomarker for neuromyelitis optica spectrum disorder. The ultimate goal of future research is to identify non-invasive biomarkers with high sensitivity, specificity, and safety for the accurate diagnosis of neuromyelitis optica.
Li, Xiangjun (58985764000); Zhang, Jiandong (58986154200); Zhang, Siqi (58986154300); Shi, Shengling (57877403700); Lu, Yi’An (57876459000); Leng, Ying (36843417900); Li, Chunyan (57188626212)
Biomarkers for neuromyelitis optica: A visual analysis of emerging research trends
2024
10.4103/NRR.NRR-D-24-00109
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85190380344&doi=10.4103%2fNRR.NRR-D-24-00109&partnerID=40&md5=6c40aa82c009676e0dff6b0f9113dbd5
Department of Ophthalmology, Affiliated Hospital of Beihua University, Jilin Province, Jilin, China; Department of Ophthalmology, Changchun Bright Eye Hospital, Jilin Province, Changchun, China; Departemt of Endocrinology, Affiliated Hospital of Beihua University, Jilin Province, Jilin, China
All Open Access; Gold Open Access
Scopus
Artículo obtenido de:
Scopus
Fuente
0 0 votos
Califica el artículo
Subscribirse
Notificación de
Campus Samborondón
Vía Samborondón Km. 13.5
Call Center: 5150400
metricas@ecotec.edu.ec
Facebook Instagram Youtube

Mapa del sitio